Form 4: Orthopediatrics Corp. COO and CFO Fred Hite Reports Stock Transactions

Fred Hite, COO and CFO of Orthopediatrics Corp., reports acquisition of shares via vesting and disposition of shares to cover tax obligations.

Summary

• On March 15, 2025, Fred Hite acquired 63,342 shares of Orthopediatrics Corp. common stock at $0.
• Following this transaction, Hite directly owned 214,432 shares.
• On March 18, 2025, Hite sold 6,443 shares at $24.86 per share.
• After the sale, Hite directly owns 207,989 shares, including 150,360 restricted stock awards.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions appear routine, with stock acquisition due to vesting and sales to cover tax obligations. No strong positive or negative signals are evident.

Positives

• The acquisition of 63,342 shares indicates confidence in the company.

Negatives

• The sale of 6,443 shares, even for tax purposes, could be perceived negatively by some investors.

Risks

• Executive stock sales can sometimes signal a lack of confidence, although this sale is attributed to tax obligations.

Industry Context

Insider transactions are common and closely monitored in the healthcare industry to ensure compliance and transparency.

Comparison to Industry Standards

• Monitoring insider transactions is a standard practice across publicly traded companies, especially in sectors like healthcare where regulatory scrutiny is high.
• Comparable companies like Stryker or Medtronic also have executives who regularly report stock transactions via Form 4 filings.

Stakeholder Impact

• The transactions may have a minor impact on shareholders' perception of the company's stock.

Key Dates